IP Verse

Dr Volger patent opposition analysis

The comprehensive analysis of Dr Volger opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Dr Volger

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3512505	Vildagliptin Pharmaceutical Compositions	GALENICUM HEALTH S.L.U.	Dec 13, 2023	KNPP
EP3517539	Substituted Dimeric Quinazoline Derivative, Its Preparation And Its Use In Pharmaceutical Compositions For The Treatment Of Type I And Ii Diabetes	BOEHRINGER INGELHEIM	Sep 14, 2023	KNPP

Top companies who are the clients of Dr Volger

Company	Total
KNPP	2